Facebook Pixel Code
About Sickkids
About SickKids

July 4, 2012

Dell named as first-ever paediatrician to become director of the largest Clinical Epidemiology and Health Care Research Program

By Daniella Vasilovsky

Dr. Sharon Dell
, Staff and Clinical Investigator, Respiratory Medicine, Senior Associate Scientist, Child Health Evaluative Sciences (CHES) and Associate Professor at the University of Toronto, was recently appointed as director of the Clinical Epidemiology and Health Care Research Program at the Institute of Health, Policy, Management and Evaluation (IHPME), University of Toronto.

IHPME is a collaboration of leading researchers from diverse disciplines that develop and translate their innovative ideas into evidence-informed practices to improve the planning, delivery and outcomes of health care. The institute has been recognized internationally for its excellence in decision sciences research and health services.

“The program is one of the best, if not the best, of its kind in the world,” says Dell. “Graduates of our program take up clinician scientist and investigator positions in prestigious academic and governmental institutions around the world. I am humbled by the quality of our faculty and graduates and I feel honoured to be the next director.”

Dr. Martin Offringa, Program Head, CHES and Dr. Janet Rossant, SickKids Chief of Research, both attest to the significant research expertise, commitment and leadership skills Dell has portrayed during her work at SickKids.

“What is really exciting is that she is now in a position to inspire more students to take on the much needed clinical research questions that are facing us – and use the best clinical research methods available,” said Dr. Offringa. “Her appointment creates further opportunity to highlight the importance of child health clinical epidemiological research in the Toronto downtown core.”

Dell has been a clinical investigator in respiratory medicine at SickKids for over 10 years. Her main clinical and research interest is in children’s airway diseases, with particular focus on asthma, primary ciliary dyskinesia and interstitial lung disease.